Asia/Pacific March 06, 2019 / 03:02 pm UTC

India: Trump’s Next Target

By Charu Chanana

Bottom line: U.S. President Donald Trump announced on Tuesday the removal of preferential trade treatment for India on goods worth more than $5 billion due to the lack of reciprocal market access. Although direct loss of benefit may be limited, the move will likely make Indian imports less competitive in the U.S. markets, and may increase the fiscal burden for India to support its key sectors. It is another blow to Prime Minister Narendra Modi’s re-election bid in this year’s national elections. We believe India will maintain a firm stance, and trade negotiations will follow.

Figure 1: India’s Exports to the U.S. Have Increased Substantially Over the Years; Imports from the U.S. Have Been Broadly Stable (USD billions)

Source: Macrobond, Continuum Economics

Shifting Battlegrounds

With the U.S.-China trade war on a temporary truce, Trump is starting to go after his next target. He decided to end preferential trade treatment for India, which allows a duty exemption on more than $5 billion worth of its goods coming into the U.S. This comes on the grounds of a lack of market access from India, especially at the expense of U.S. dairy suppliers and medical device manufacturers. 

Indian officials downplayed the impact of the move, saying the preferential treatment brought benefits of just around $200 million annually. India exported around $50 billion worth of goods to the United States in 2017 (Figure 1), and was the largest beneficiary of the Generalized System of Preferences (GSP) import scheme (Figure 2). Being one of the largest economies of the world, this preferential treatment—which is meant to help develop the markets in the least-developed countries—does seem dispensable. However, it is symbolic of the strategic relationship between the two countries in their common animosity toward China. 

Competitiveness at Risk

While the stated benefits of the GSP to India are about $200 million, India loses export competitiveness for goods worth $5.6 billion, especially to markets such as Mexico that have FTAs with the U.S., or others like Bangladesh and Vietnam, which continue to enjoy GSP benefits. Some of the industries that saw large amounts of GSP benefit and may likely be impacted include organic chemicals, plastics and cement. 

More importantly, India predominantly exports intermediate and semi-manufactured goods to the U.S. under the GSP, and the loss of price advantage in these could mean a further setback for employment and jobs in the manufacturing sector. There will, however, be some offset from India’s efforts to diversify to Latin American, African as well as ASEAN markets.

Figures 2 and 3: India Is the Largest Beneficiary of the U.S. GSP Import Scheme (USD billions); Some Industries Receive Tariff Waivers for Over $500 Million Worth of Exports (USD millions)

Source: U.S. International Trade Commission Data Web, Continuum Economics

What matters even more will be the political impact, given the Indian national elections this year. Modi’s re-election has been in question because of his unpopular reforms such as demonetization and introduction of GST. His foreign policy setbacks will only further add to the woes. 


We expect the impact of these measures to be non-uniform across sectors. While some exporters who face duty loss of 2-3% may face margin pressures, others who had a higher GSP tariff advantage may need targeted support. This could be a fiscal burden for the Indian economy, which is already struggling to remain on the path of fiscal consolidation.

However, as these changes may not take effect for another 60 days, we believe it opens the door for U.S.-India trade negotiations–and a trade deal may be on the table. This will be more likely if India adopts a firm stance and imposes retaliatory tariffs on U.S. goods, which were proposed in June 2018 but have been continually postponed and are now scheduled to go in effect on April 1. 

4Cast Ltd. and all of its affiliates (Continuum Economics) do not conduct “investment research” as defined in the FCA Conduct of Business Sourcebook (COBS) section 12 nor do they provide “advice about securities” as defined in the Regulation of Investment Advisors by the U.S. SEC. Continuum Economics is not regulated by the SEC or by the FCA or by any other regulatory body. This research report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Nonetheless, Continuum Economics has an internal policy that prohibits “front-running” and that is designed to minimize the risk of receiving or misusing confidential or potentially material non-public information. The views and conclusions expressed here may be changed without notice. Continuum Economics, its partners and employees make no representation about the completeness or accuracy of the data, calculations, information or opinions contained in this report. This report may not be copied, redistributed or reproduced in part or whole without Continuum Economics’s express permission. Information contained in this report or relied upon in its construction may previously have been disclosed under a consulting agreement with one or more clients. The prices of securities referred to in the report may rise or fall and past performance and forecasts should not be treated as a reliable indicator of future performance or results. This report is not directed to you if Continuum Economics is barred from doing so in your jurisdiction. Nor is it an offer or solicitation to buy or sell securities or to enter into any investment transaction or use any investment service.
Analyst Certification
I, Charu Chanana, the lead analyst certify that the views expressed herein are mine and are clear, fair and not misleading at the time of publication. They have not been influenced by any relationship, either a personal relationship of mine or a relationship of the firm, to any entity described or referred to herein nor to any client of Continuum Economics nor has any inducement been received in relation to those views. I further certify that in the preparation and publication of this report I have at all times followed all relevant Continuum Economics compliance protocols including those reasonably seeking to prevent the receipt or misuse of material non-public information.